These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23062704)

  • 1. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.
    Kotikam V; Rozners E
    Acc Chem Res; 2020 Sep; 53(9):1782-1790. PubMed ID: 32658452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of siRNAs that contain internal variable-length spacer linkages.
    Efthymiou TC; Peel B; Huynh V; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5590-4. PubMed ID: 22850216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Activity of Short Interfering RNAs Having Several Consecutive Amide Internucleoside Linkages.
    Kotikam V; Viel JA; Rozners E
    Chemistry; 2020 Jan; 26(3):685-690. PubMed ID: 31693228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amides are excellent mimics of phosphate internucleoside linkages and are well tolerated in short interfering RNAs.
    Mutisya D; Selvam C; Lunstad BD; Pallan PS; Haas A; Leake D; Egli M; Rozners E
    Nucleic Acids Res; 2014 Jun; 42(10):6542-51. PubMed ID: 24813446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
    Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
    Iwase R; Toyama T; Nishimori K
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
    Iwase R; Miyao H; Toyama T; Nishimori K
    Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient synthesis and cell-based silencing activity of siRNAS that contain triazole backbone linkages.
    Efthymiou TC; Huynh V; Oentoro J; Peel B; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1722-6. PubMed ID: 22260772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
    Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide linkages mimic phosphates in RNA interactions with proteins and are well tolerated in the guide strand of short interfering RNAs.
    Mutisya D; Hardcastle T; Cheruiyot SK; Pallan PS; Kennedy SD; Egli M; Kelley ML; Smith AVB; Rozners E
    Nucleic Acids Res; 2017 Aug; 45(14):8142-8155. PubMed ID: 28854734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
    Chang C; Hong SW; Dua P; Kim S; Lee DK
    Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and gene silencing properties of siRNAs containing terminal amide linkages.
    Gaglione M; Mercurio ME; Potenza N; Mosca N; Russo A; Novellino E; Cosconati S; Messere A
    Biomed Res Int; 2014; 2014():901617. PubMed ID: 24791003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion.
    Zhao HF; L'Abbé D; Jolicoeur N; Wu M; Li Z; Yu Z; Shen SH
    Nat Methods; 2005 Dec; 2(12):967-73. PubMed ID: 16299483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.